1. Home
  2. ARCT vs LYTS Comparison

ARCT vs LYTS Comparison

Compare ARCT & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • LYTS
  • Stock Information
  • Founded
  • ARCT 2013
  • LYTS 1976
  • Country
  • ARCT United States
  • LYTS United States
  • Employees
  • ARCT N/A
  • LYTS N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • LYTS Building Products
  • Sector
  • ARCT Health Care
  • LYTS Consumer Discretionary
  • Exchange
  • ARCT Nasdaq
  • LYTS Nasdaq
  • Market Cap
  • ARCT 320.8M
  • LYTS 549.1M
  • IPO Year
  • ARCT N/A
  • LYTS N/A
  • Fundamental
  • Price
  • ARCT $17.32
  • LYTS $22.47
  • Analyst Decision
  • ARCT Strong Buy
  • LYTS Strong Buy
  • Analyst Count
  • ARCT 10
  • LYTS 2
  • Target Price
  • ARCT $50.88
  • LYTS $27.50
  • AVG Volume (30 Days)
  • ARCT 548.9K
  • LYTS 267.8K
  • Earning Date
  • ARCT 11-06-2025
  • LYTS 11-06-2025
  • Dividend Yield
  • ARCT N/A
  • LYTS 0.89%
  • EPS Growth
  • ARCT N/A
  • LYTS N/A
  • EPS
  • ARCT N/A
  • LYTS 0.79
  • Revenue
  • ARCT $122,122,000.00
  • LYTS $573,377,000.00
  • Revenue This Year
  • ARCT N/A
  • LYTS $6.88
  • Revenue Next Year
  • ARCT $31.09
  • LYTS $6.95
  • P/E Ratio
  • ARCT N/A
  • LYTS $28.44
  • Revenue Growth
  • ARCT N/A
  • LYTS 22.09
  • 52 Week Low
  • ARCT $8.04
  • LYTS $13.77
  • 52 Week High
  • ARCT $25.88
  • LYTS $25.50
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 54.49
  • LYTS 58.27
  • Support Level
  • ARCT $17.38
  • LYTS $22.06
  • Resistance Level
  • ARCT $18.69
  • LYTS $23.89
  • Average True Range (ATR)
  • ARCT 1.00
  • LYTS 0.77
  • MACD
  • ARCT -0.11
  • LYTS -0.14
  • Stochastic Oscillator
  • ARCT 44.23
  • LYTS 28.64

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays and custom display elements.

Share on Social Networks: